TNFSF10 and melanoma: As the TRAIL signaling pathway was also functional in the low NK-sensitive melanoma cell lines, we investigated whether inhibition of NK cell killing in cell lines WM-1366 and WM-3248 was due to checkpoint inhibition, of which the PD-L1/PD-1 checkpoint has been shown to be of major clinical relevance in melanoma.